In the News / Politics

AstraZeneca Sells Rights to Two Cardiovascular Drugs for $400 Million

By: Jennifer Galvet, PharmD Candidate c/o 2024 Introduction The British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has agreed to sell…

5 years ago

Flu Shot Season, COVID-19 and How Pharmacies are Bracing for Impact

By: Rebecca Samuel, PharmD Candidate c/o 2022 and Pallak Sharma, PharmD Candidate c/o 2022              It is flu shot season!…

5 years ago

Daniel Schneider RPh.’s crusade against OxyContin

By: Alisha Kuriakose, PharmD Candidate c/o 2022 “The Pharmacist” is a Netflix documentary that showcases pharmacist Dr. Daniel Schneider’s crusade…

5 years ago

EndeavourRx ™: The Prescription-Only, FDA-Approved Videogame for Children with ADHD

By: Aiśa Mrkulic PharmD Candidate c/o 2022              Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common reasons…

5 years ago

NMOSD Treatment

By: Lyana Sayilar PharmD. Candidate c/o 2022              Neuromyelitis optica spectrum disorder (NMOSD) is a rare disorder affecting 4,000 to…

5 years ago

FDA Approves GlaxoSmithKline’s Combined Formulation of Ibuprofen-Acetaminophen: Is This a Step in the Direction of Increased Patient Adherence in Pain Relief and the Fight Against the Opioid Epidemic?

By: Edwin Gruda, PharmD Candidate c/o 2022; Aiśa Mrkulic, PharmD. Candidate c/o 2022              Over-the-Counter (OTC) medications are typically used…

5 years ago

Next Up in the World of Hyperlipidemia: Nexletlol TM

By: Preethi Samuel, Pharm.D. Candidate c/o of 2021              In the United States, at least one person has a heart…

6 years ago

MIS-C: The Impact of COVID-19 on the Pediatric Population

By: Erica Tonti, PharmD Candidate c/o 2022 Multisystem Inflammatory Syndrome in Children, or MIS-C, is a recent syndrome recognized by…

6 years ago

A New Drug Class for Heart Failure—Dapagliflozin’s New Groundbreaking Indication for Heart Failure with Reduced Ejection Fraction (HFrEF)

By: Adrian Wong, PharmD Candidate c/o 2021 On May 5, 2020, the Food and Drug Administration (FDA) announced its approval…

6 years ago

Provider Status: What is it?

By: Katharine Russo, PharmD Candidate c/o 2021              As of July 1, 2000, the Accreditation Council for Pharmacy Education (ACPE)…

6 years ago